Results 61 to 70 of about 12,443,450 (160)

Metabolic effects of exercise in patients with type IV hyperlipoproteinemia [PDF]

open access: yes, 1970
Metabolic responses to 30 minutes of submaximal exercise were investigated in 11 healthy control subjects and 6 patients with type IV hyperlipoproteinemia (endogenous or essential hypertriglyceridemia). All subjects were male and ranged in age from 35 to
Conway, James   +2 more
core   +1 more source

Beyond lipids: Systemic effects of lipoprotein apheresis

open access: yes
Transfusion, Volume 66, Issue 3, Page 590-598, March 2026.
Menatalla Nadim, Yamac Akgun
wiley   +1 more source

Finerenone in diabetic chronic kidney disease—Real‐world insights including patients with HFpEF or HFmrEF

open access: yesESC Heart Failure, Volume 12, Issue 6, Page 4219-4229, December 2025.
Abstract Purpose Finerenone, a highly selective non‐steroidal mineralocorticoid receptor antagonist, was approved for the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (diabetic kidney disease, DKD). Finerenone reduced the composite endpoint of heart failure events and cardiovascular death in patients with heart ...
Kristian Hellenkamp   +9 more
wiley   +1 more source

Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome [PDF]

open access: yes, 1987
The mechanism leading to hyperlipidemia in the nephrotic syndrome is not fully understood but may be related in part to loss of high density lipoproteins in the urine of patients with nephrosis.
Caselmann, Wolfgang H.   +3 more
core   +1 more source

Diagnostic Utility of Liver Biopsy in Persistent Unexplained Liver Enzyme Elevation: A Retrospective Cohort Study

open access: yesJGH Open, Volume 9, Issue 11, November 2025.
ABSTRACT Background and Aims Chronically elevated liver enzymes without a clear etiology remain a frequent diagnostic challenge. This study evaluated the diagnostic yield of liver biopsy in such cases and assessed if laboratory parameters predict histological clarification. Methods We retrospectively analyzed 71 patients with unexplained elevated liver
S. Jaawan   +8 more
wiley   +1 more source

A Case of Type V Hyperlipoproteinemia with Xanthoma Eruptivum

open access: yes, 2001
We report a case of type V hyperlipoproteinemia with xanthoma eruptivum in a 30-year-old male. He had diffuse erythematous yellowish papules on both extremities and the buttock.
방동식
core  

Phenotyping of type II and IV hyperlipoproteinemias by a simple, quantitative agarose gel lipoprotein electrophoresis

open access: yes, 1971
From the statistical analysis of the densitometric percentage counts derived from 97 lipoprotein electrophoreses from patients with Type II or Type IV hyperlipoproteinemia, we developed a simple sequential screening approach.
R. Hassanein   +3 more
core   +1 more source

A Review of Plasma Lipids and Their Transport and a Study of Neonatal Familial Type II Hyperlipoproteinemia

open access: yes, 1970
v, 31 p.The general field of hyperlipoproteinemia has been recognized by scientists and doctors for a relatively short time. Even at the present time only people who live in large urban areas where this medical research is being carried on have ...
Dwyer, Rosalind
core   +1 more source

The Role of Genetics in Stroke Risk and Outcome: A Review of Current Evidence

open access: yesBrain and Behavior, Volume 15, Issue 10, October 2025.
This study delineates the multiple pathways leading to stroke, encompassing genetic risk factors such as lipid/cholesterol metabolism, blood pressure regulation genes, and endothelial dysfunction. The report includes genetic pathways such as Val66Met polymorphism, prothrombin G20210A, interleukin‐6 and tumor necrosis factor gene variant, along with ...
Mega Obukohwo Oyovwi   +3 more
wiley   +1 more source

The effect of glucagon in various types of primary hyperlipoproteinemia

open access: yes, 1970
In order to further assess lipid-carbohydrate interactions in familial hyperlipoproteinemia, the acute and chronic effects of glucagon (3 mg i.m.) on plasma total cholesterol, triglycerides, non-esterified fatty acids and glucose were studied in 24 ...
Aubry, Francine
core  

Home - About - Disclaimer - Privacy